Results 161 to 170 of about 22,676 (187)

Precision prediction of venetoclax-azacitidine treatment efficacy in acute myeloid leukemia via integrative drug screening and machine learning. [PDF]

Cell Rep Med
Jin P, Wang D, Shen J, Jin Q, Zhang H, Liu X, He M, Jin W, Li Y, Dong F, Jin F, Yang Y, Zheng R, Wang S, Guo J, Li S, Liu D, Yan Z, Jin C, Xu B, Guo W, Zhu H, Zhang Y, Jin Z, Wang K.   +24 more
europepmc   +1 more source

Impact of venetoclax trough levels on safety and efficacy in the treatment of acute myeloid leukemia. [PDF]

Sci Rep
Hayashi H, Yamagiwa T, Kanda J, Ishikawa T, Sawa M, Miyahara Y, Tachibana T, Watanabe M, Ueda Y, Tsutsumi Y, Imada K, Fujiwara SI, Toubai T, Yoshifuji K, Hirata H, Kawabata H, Tsuji M, Wakita S, Yokoyama H, Kitano T, Murai K, Kataoka Y, Kawata E, Kimura SI, Yamamoto R, Miyao K, Nakayama D, Izumi A, Kawata T, Onda Y, Sakamoto T, Mizumoto C, Kitawaki T, Yamashita K, Yonezawa A, Kawakami T, Nakagawa S, Taniguchi R, Terada T, Takaori-Kondo A.   +39 more
europepmc   +1 more source

Comparing the efficacy and safety of the ABC-14 regimen (azacitidine, venetoclax, and chidamide) with traditional "3 + 7" intensive induction regimen or AB-14 regimen (venetoclax combined with azacitidine) in newly diagnosed AML: study protocol for a prospective, multicenter, randomized, open-label clinical trial. [PDF]

Trials
Yan H, Huang X, Wu P, Deng C, Li M, Lai P, Du X, Weng J.   +7 more
europepmc   +1 more source

An emerging triplet option for newly diagnosed <i>FLT3</i>-mutated acute myeloid leukemia. [PDF]

Haematologica
Boussi L, Goldberg AD.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Azacitidine

Nature Reviews Drug Discovery, 2005
Azacitidine (Vidaza; Pharmion), an inhibitor of DNA methylation, was approved by the US FDA for the treatment of myelodysplastic syndromes in May 2004. It is the first drug to be approved by the FDA for treating this rare family of bone-marrow disorders, and has been given orphan-drug status.
Jean-Pierre J, Issa, Hagop M, Kantarjian, Peter, Kirkpatrick   +2 more
  +7 more sources

Azacitidine

Reactions Weekly, 2017
  +7 more sources